Current and historical daily PE Ratio for Cytophage Technologies Ltd (
) from 2024 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cytophage Technologies stock (TSXV:CYTO) PE ratio as of Jun 10 2024 is 0.
More Details
Cytophage Technologies Ltd (TSXV:CYTO) PE Ratio (TTM) Chart
Cytophage Technologies Ltd (TSXV:CYTO) PE Ratio (TTM) Historical Data
View and export this data going back to 2024. Start your Free Trial
Total 84
- 1
| Cytophage Technologies PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | At Loss | 2024-04-10 | At Loss |
| 2024-06-07 | At Loss | 2024-04-09 | At Loss |
| 2024-06-06 | At Loss | 2024-04-08 | At Loss |
| 2024-06-05 | At Loss | 2024-04-05 | At Loss |
| 2024-06-04 | At Loss | 2024-04-04 | At Loss |
| 2024-06-03 | At Loss | 2024-04-03 | At Loss |
| 2024-05-31 | At Loss | 2024-04-02 | At Loss |
| 2024-05-30 | At Loss | 2024-04-01 | At Loss |
| 2024-05-29 | At Loss | 2024-03-28 | At Loss |
| 2024-05-28 | At Loss | 2024-03-27 | 20.2 |
| 2024-05-27 | At Loss | 2024-03-26 | 17.8 |
| 2024-05-24 | At Loss | 2024-03-25 | 19.6 |
| 2024-05-23 | At Loss | 2024-03-22 | 21.1 |
| 2024-05-22 | At Loss | 2024-03-21 | 22.6 |
| 2024-05-21 | At Loss | 2024-03-20 | 21.7 |
| 2024-05-17 | At Loss | 2024-03-19 | 21.3 |
| 2024-05-16 | At Loss | 2024-03-18 | 20.9 |
| 2024-05-15 | At Loss | 2024-03-15 | 21.7 |
| 2024-05-14 | At Loss | 2024-03-14 | 20.9 |
| 2024-05-13 | At Loss | 2024-03-13 | 21.7 |
| 2024-05-10 | At Loss | 2024-03-12 | 23.5 |
| 2024-05-09 | At Loss | 2024-03-11 | 23.5 |
| 2024-05-08 | At Loss | 2024-03-08 | 23.5 |
| 2024-05-07 | At Loss | 2024-03-07 | 23.0 |
| 2024-05-06 | At Loss | 2024-03-06 | 20.6 |
| 2024-05-03 | At Loss | 2024-03-05 | 20.4 |
| 2024-05-02 | At Loss | 2024-03-04 | 22.2 |
| 2024-05-01 | At Loss | 2024-03-01 | 22.6 |
| 2024-04-30 | At Loss | 2024-02-29 | 21.3 |
| 2024-04-29 | At Loss | 2024-02-28 | 21.3 |
| 2024-04-26 | At Loss | 2024-02-27 | 21.7 |
| 2024-04-25 | At Loss | 2024-02-26 | 22.2 |
| 2024-04-24 | At Loss | 2024-02-23 | 26.1 |
| 2024-04-23 | At Loss | 2024-02-22 | 24.8 |
| 2024-04-22 | At Loss | 2024-02-21 | 25.2 |
| 2024-04-19 | At Loss | 2024-02-20 | 22.6 |
| 2024-04-18 | At Loss | 2024-02-16 | 18.9 |
| 2024-04-17 | At Loss | 2024-02-15 | 18.3 |
| 2024-04-16 | At Loss | 2024-02-14 | 20.2 |
| 2024-04-15 | At Loss | 2024-02-13 | 22.2 |
| 2024-04-12 | At Loss | 2024-02-12 | 24.8 |
| 2024-04-11 | At Loss | 2024-02-09 | 27.4 |
Cytophage Technologies Ltd (TSXV:CYTO) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cytophage Technologies Ltd
NAICS : 541713
SIC : 3741
Description
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers